Amino Acids: Clinical Trials

88 trials of Amino Acids, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 completed, 9 unknown, 8 withdrawn, 7 recruiting. 59 Not applicable, 9 Phase 2, 8 Phase 4, 6 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable59Completed 39, Unknown 8, Recruiting 4, Active not recruiting 2, Suspended 2, Withdrawn 2, Not yet recruiting 1, Terminated 1
Phase 29Completed 4, Withdrawn 4, Not yet recruiting 1
Phase 48Recruiting 2, Terminated 2, Active not recruiting 1, Completed 1, Enrolling by invitation 1, Withdrawn 1
Phase 16Completed 3, Terminated 1, Unknown 1, Withdrawn 1
Phase 34Completed 4
Early Phase 11Completed 1

Follow Amino Acids: new trials by email Literature Review of Amino Acids trials Research Report on Amino Acids

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimal Protein Intake to Maximize Whole-Body Protein Balance in Healthy Adults
Amino Acid - Protein Metabolism
Not applicableNot yet recruitingMaastricht University Medical Center122026-08-012026-04-29
Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus
Muscle Biopsy, Jell-O with Amino acids, Dextrose - Type 1 Diabetes
Not applicableWithdrawnMayo Clinic2026-06-012026-08-05
Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients
amino acid (15) peritoneal dialysis solution - End-stage Renal Disease (ESRD), Peritoneal Dialysis (PD)
Phase 4Enrolling by invitationShanghai 10th People's Hospital502026-05-012026-04-28
Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists
Drinkable multifactorial food supplement containing vitamins, minerals, amino acids, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women +45., Placebo control - Telogen Effluvium
Not applicableRecruitingOlistic Research Labs S.L.402026-03-162026-10-06
Essential Amino Acids and Parkinsons Disease
AMS2434 (amino acids), Placebo - Parkinson Disease
Phase 1WithdrawnUniversity of Arkansas2026-03-092026-03-12
Hyaluronic Acid and Amino Acid Combination Versus Exercise for Chronic Lateral Epicondylitis
Hyaluronic Acid + Amino Acid Injection, Home Exercise Program - Lateral Epicondylitis
Active not recruitingSivas State Hospital602025-12-012026-02-13
Amino Acids for Cardiac Surgery Associated AKI
Amino Acids, Placebo - Acute Kidney Injury
Phase 2Not yet recruitingStanford University302025-09-012025-06-03
Clinical Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers
Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, amino acids, and other bioactive compounds, formulated to support hair growth and scalp health in women., Placebo control - Early Female Pattern Hair Loss (FPHL)
Not applicableActive not recruitingOlistic Research Labs S.L.602025-03-032026-07-22
Branched Chain Amino Acids for Sarcopenia in Patients Undergoing Total Knee Arthroplasty
Livact Granule - Sarcopenia, Total Knee Arthroplasty
Phase 4RecruitingSeoul National University Hospital1402025-02-062026-06-09
Acute Effects of BCAA and L-Arginine on Performance in Elite Soccer Players
BCAA, L-Arginine, bcaa and l arginine - Ergogenic Support and Performance
Not applicableCompletedAtaturk University212025-01-102026-01-16
Efficacy and Safety Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers
Drinkable multifactorial food supplement containing vitamins, minerals, amino acids, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women +50. - Early Female Pattern Hair Loss (FPHL)
Not applicableCompletedOlistic Research Labs S.L.392024-09-162026-01-12
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
amino acid (15) peritoneal dialysis solution, glucose peritoneal dialysis solution - End Stage Renal Disease (ESRD)
Phase 4RecruitingChengdu Qingshan Likang Pharmaceutical Co., Ltd4002024-08-092024-12-30
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
Multinutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants - Attention Deficit/Hyperactivity Disorder, Emotional Dysfunction
Not applicableRecruitingOregon Health and Science University302024-01-062025-01-16
Beverage Hydration Index: Assessment of Four Rehydration Solutions
Multiplier, Sugar Free, Sugar Free with Amino Acids - Hydration
Not applicableCompletedUniversity of Memphis282023-12-232024-12-16
Feasibility Nutritional Supplements for Muscle Growth in CP
Dietary Supplement: Leucine - Spastic Cerebral Palsy
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven52023-07-312026-05-05
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
Dextrose, Clinisol 15% - Healthy, Type 2 Diabetes
Phase 4Active not recruitingMayo Clinic302023-05-302026-02-13
Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer
amino acid tablet - Amino Acid Deficiency, Malnutrition
Not applicableUnknownBeijing Chest Hospital862023-04-152023-03-15
Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)
Branch Chain Amino Acid, Lactulose - Hepatic Encephalopathy, Acute-On-Chronic Liver Failure
Phase 1CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1142023-01-172025-06-08
Nutritional Assesment in Patients With Cirrhosis
BCAA - Cirrhosis, Liver
RecruitingSUUMC Central Military Hospital Dr Carol Davila502023-01-012024-12-19
Investigating the Anabolic Response to Resistance Exercise During Critical Illness
Resisted knee extension exercise, IV amino acids - Critical Illness, Muscle Loss
Not applicableSuspendedKarolinska University Hospital242022-12-252024-03-07

Showing 20 of 88. Sign in to see all of them.

Conditions studied

Sarcopenia (6)  ·  Malnutrition (5)  ·  Diabetes Mellitus, Type 2 (4)  ·  Insulin Resistance (4)  ·  Liver Cirrhosis (4)  ·  Motor Activity (4)  ·  Brain Injuries, Traumatic (3)  ·  Critical Illness (3)  ·  Hepatic Encephalopathy (3)  ·  Hyperphagia (3)  ·  Metabolic Syndrome (3)  ·  Muscular Atrophy (3)  ·  Acute Kidney Injury (2)  ·  Attention Deficit Disorder with Hyperactivity (2)  ·  Cerebral Palsy (2)

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre (4)  ·  Colgate Palmolive (3)  ·  Maastricht University Medical Center (3)  ·  Mayo Clinic (3)  ·  Olistic Research Labs S.L. (3)  ·  DoubleGood AB (2)  ·  Oregon Health and Science University (2)  ·  Purdue University (2)  ·  The University of Texas Medical Branch, Galveston (2)  ·  University of Aarhus (2)  ·  University of Arkansas (2)  ·  University of Florida (2)  ·  University of Memphis (2)  ·  Arnold Kristof (1)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

United States (33)  ·  Canada (8)  ·  China (4)  ·  India (3)  ·  Netherlands (3)  ·  Spain (3)  ·  Switzerland (3)  ·  Denmark (2)  ·  Egypt (2)  ·  France (2)  ·  Germany (2)  ·  Sweden (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  Belgium (1)

Top investigators

Chad C Carroll, PhD (2)  ·  Richard Bloomer, PhD (2)  ·  Adrian Vella, MD (1)  ·  Agneta L. Sunehag (1)  ·  Alexander Kulagin, Professor (1)  ·  Arnold S Kristof, MDCM, FRCPC (1)  ·  Bennet Amaechi, PhD, DDS (1)  ·  Cathey Powers, MD (1)  ·  Cynthia Neill Epperson, M.D. (1)  ·  Dale M Needham, MD, PhD (1)  ·  Daren K Heyland, MD, MSc (1)  ·  David Mayman, MD (1)  ·  Du Hyun Ro, MD, PhD (1)  ·  Elena Volpi, MD,PhD (1)

Results publications

PMID 33006765, PMID 34920728, PMID 10950834, PMID 11145118, PMID 11172481, PMID 11238483, PMID 12145777, PMID 12399273, PMID 12450897, PMID 12915639, PMID 1406301, PMID 14522731, PMID 1460185, PMID 14767878, PMID 15331548, PMID 1588830, PMID 16423633, PMID 16941278, PMID 18029478, PMID 19013300, PMID 19092350, PMID 19158217, PMID 19515736, PMID 19553295, PMID 1959475, PMID 20150602, PMID 20444922, PMID 20882645, PMID 21084649, PMID 21367943, PMID 21430249, PMID 2195298, PMID 2197851, PMID 2209312, PMID 22338070, PMID 22569039, PMID 22878551, PMID 23034968, PMID 23607614, PMID 25527663, PMID 26155840, PMID 26690886, PMID 2673694, PMID 26765812, PMID 26959710, PMID 26962179, PMID 27707724, PMID 27908546, PMID 28951631, PMID 29389088

NIH funding

R01CA167632 (2), I01CX002022 (1), P50MH099910 (1), R01AG030070 (1), R01AG033761 (1), R01DK116231 (1), R01ES014617 (1)